In short: Bringing a European ingredient to the U.S. market takes more than a good product: it takes a full landed-cost model, a product-specific regulatory path, local trust, and a delivery plan. There is no single “FDA approval” for every ingredient, and requirements such as facility registration, prior notice, and FSVP depend on the product. For many manufacturers, the sensible sequence is to prove demand with a U.S. partner first, then invest in owned infrastructure once repeat business supports it.
A great product can open the door to the U.S. market. It cannot, by itself, get an order through customs, onto a customer’s production schedule, or into a buyer’s shortlist.
That takes a plan for the full journey: compliance, landed cost, inventory, delivery, and trust. For many international manufacturers, those are the real tests of U.S. market entry, not product quality alone.
The price is not the landed cost
A European factory price is only the starting point. To understand what a U.S. customer will actually pay, and whether your margins can survive, you need to map the full cost stack.
Your landed-cost model may need to include:
- International freight: ocean or air transport, insurance, fuel surcharges, and possible delays.
- Tariffs and customs: duties depend on factors such as product classification, country of origin, and current trade rules. Don’t assume one rate applies to every item or shipment.
- Documentation and brokerage: customs entry, product records, certificates, and the work needed to correct missing or inconsistent information.
- Warehousing and handling: storage, receiving, pallet movement, inventory management, and any special conditions the product requires.
- Last-mile delivery: moving stock from a U.S. port or warehouse to a customer’s facility.
- Time and coordination: managing suppliers, brokers, customers, and exceptions across time zones.
That last line is easy to overlook. A small documentation issue can become a long email chain when the people who can resolve it are asleep on the other side of the Atlantic.
Model more than one scenario: a planned ocean shipment, a faster replenishment option, and the cost of holding U.S. safety stock. Then compare the delivered cost and service level, not just the unit price at origin.
Regulatory readiness is product-specific, and timing is not a promise
There is no single “FDA approval” that covers every ingredient entering the United States. The requirements depend on what the product is, how it will be used, what claims are made, and which U.S. agency has jurisdiction. Food ingredients, dietary-supplement components, cosmetics, pharmaceutical ingredients, and pesticides can follow different regulatory routes.
For food, FDA says imported products must meet applicable U.S. requirements. Depending on the product and supply chain, that can involve facility registration, prior notice, labeling, and a U.S. importer’s Foreign Supplier Verification Program (FSVP). FDA’s import guidance and FSVP requirements are useful starting points. Neither facility registration nor prior notice should be mistaken for a blanket product approval.
For products in other categories, additional or different requirements may apply. Build time to confirm the product’s classification, review its label and claims, prepare supporting documents, and establish who is responsible for each import and compliance task. FDA inspections, examinations, and shipment reviews can also affect release timing. Agency priorities and procedures can change, so no one should treat an estimated review period as a guaranteed clearance date.
The practical move: get a product-specific U.S. regulatory assessment before promising customers a launch date.
Unknown brand. Known market. Build trust locally.
American buyers may be open to a new product, but they still need reasons to take a chance on an unfamiliar supplier. They want confidence in quality, documentation, availability, and support when a question arises.
A local presence helps make those answers tangible. That might mean a U.S.-based sales contact, a distributor with relevant customer relationships, or a partner that can hold stock and respond during U.S. business hours. A U.S. market-entry guide from Capteeni also emphasizes the value of local outreach and carefully selecting channel partners.
For a supplier, the goal is not simply to be listed in a catalog. It is to make it easier for a buyer to evaluate the product, obtain samples, review documentation, and place a first order without feeling that every step depends on a distant office.
Plan the delivery before the first order
The delivery plan is part of the offer. A customer may value a competitive price, but the price loses its shine if the material arrives after a production window has passed.
Before launch, work through the physical flow:
- Confirm transport and transit assumptions. Build realistic buffers rather than planning around the best-case sailing or flight.
- Decide where inventory will sit. Compare direct shipment to each customer with U.S. warehouse stock close to likely demand.
- Set storage and handling requirements. Some products may require temperature control, specific packaging, or other conditions.
- Assign documentation and import responsibilities. Clarify who prepares, checks, and submits each required document, and who addresses errors.
- Plan replenishment. Set reorder triggers and safety-stock assumptions based on demand, lead time, shelf life, and cash tied up in inventory.
The right stocking strategy will differ by product and customer. But where demand is uncertain, a regional pilot can help test the market without committing to a large national footprint. Once demand becomes more predictable, local inventory can turn a long transatlantic supply line into a much more responsive service proposition.
That is the difference between selling an ocean shipment and offering bulk ingredients with fast, reliable U.S. delivery.
Partner first, or build your own?
There is no universal answer. The choice depends on demand, strategic control, capital, and how quickly you need to learn.
| Partner-first | Build owned U.S. infrastructure |
|---|---|
| Faster access to local sales, logistics, and customer networks | More direct control over customer relationships and operations |
| Lower upfront investment; useful for testing demand | Greater investment in people, facilities, systems, and compliance |
| Partner economics and priorities must be managed | More responsibility, and potentially more operational flexibility |
| Good fit for a regional launch or early market validation | Better considered when demand and long-term strategy justify the commitment |
Recent examples illustrate different approaches, not guarantees of success. In 2025, Lubrizol announced a distribution partnership with Palmer Holland to expand the reach of its European-manufactured nutraceutical and food ingredients in the Northeastern U.S. Belgium-based Belchim Crop Protection used U.S. partners for formulation and manufacturing support; its case study with CJB Applied Technologies describes efforts to localize parts of its supply chain. In 2026, Austrian company Ringana announced a planned U.S. investment in a U.S. headquarters and a local production and distribution operation in Roanoke, Virginia, an example of a more capital-intensive, owned-infrastructure path (announcement). And Medisca and EUROAPI announced a distribution partnership focused on pharmaceutical-compounding APIs, showing how a specialized channel can connect European manufacturing with North American customers.
The sensible sequence for many companies is to prove demand with a partner, then invest in owned infrastructure when repeat business supports the case. A partner should be more than a name on a contract: assess its market access, inventory capability, documentation practices, customer service, and willingness to commit to measurable goals.
McBoeck Insight: Be present before you build
McBoeck understands the bridge because we have built one ourselves. Founded in Germany in 2010, we established our U.S. hub in Houston in 2014, and we have been connecting European supply with American customers ever since. (Our history)
For an international manufacturer, a U.S.-based distribution partner can help bridge the distance between a European production site and a customer who needs material locally. Depending on the product and arrangement, that can mean U.S. inventory, customer outreach, import and logistics coordination, and documentation such as certificates of analysis. It can also let a business test demand before committing to its own U.S. entity or warehouse.
Where a program calls for it, we can help plan U.S. stocking close to demand, so delivery depends on the order, destination, and stock position rather than an ocean crossing. For buyers, a supplier with stock already in the U.S. can shorten the gap between a production need and a replenishment order, and COA-backed, traceable documentation makes it easier to evaluate quality and supply continuity.
That is not a substitute for product-specific regulatory review or a guarantee that every product fits every customer’s requirements. It is a practical way to make market entry more local, responsive, and manageable.
Make the first move a market test
Before investing in a U.S. facility, answer five questions:
- Who is the first customer segment, and why would it switch or add your product?
- What is the true landed cost at realistic order sizes?
- Which U.S. requirements apply to this specific product and intended use?
- Who will manage importing, documentation, warehousing, and customer questions?
- What evidence of repeat demand would justify deeper investment?
A strong product deserves a supply plan that can carry it across the Atlantic and into a customer’s routine. Start with a clear compliance path, a realistic delivered-cost model, and a partner who can help you learn the market on the ground.
European manufacturers evaluating U.S. entry can connect with McBoeck to discuss a partner-first path, from sourcing and U.S. stocking options to delivery.
Frequently asked questions
What costs make up the landed cost of a European ingredient in the U.S.?
Beyond the factory price, a landed-cost model may need to include international freight, tariffs and customs duties, documentation and brokerage, warehousing and handling, last-mile delivery, and the time spent coordinating suppliers, brokers, and customers across time zones.
Is there a single FDA approval for importing an ingredient into the U.S.?
No. Requirements depend on what the product is, how it will be used, what claims are made, and which U.S. agency has jurisdiction. For food, that can involve facility registration, prior notice, labeling, and the importer’s Foreign Supplier Verification Program (FSVP). Neither facility registration nor prior notice is a blanket product approval.
Should a European manufacturer partner with a U.S. distributor or build its own infrastructure?
There is no universal answer. A partner-first approach offers faster access to local sales, logistics, and customers with lower upfront investment, which suits a regional launch or demand testing. Owned infrastructure offers more direct control but requires more investment and is better considered once demand justifies it.
Why does local presence matter to U.S. buyers?
American buyers need reasons to trust an unfamiliar supplier: confidence in quality, documentation, availability, and support. A U.S.-based sales contact, a distributor with relevant relationships, or a partner that can hold stock and respond during U.S. business hours makes those answers tangible.
What should a manufacturer answer before investing in a U.S. facility?
Who the first customer segment is, the true landed cost at realistic order sizes, which U.S. requirements apply to the specific product, who will manage importing, documentation, warehousing, and customer questions, and what evidence of repeat demand would justify deeper investment.